miR133a regulates cardiomyocyte hypertrophy in diabetes. - Wikidata - awgldk - TriplyDB

miR133a regulates cardiomyocyte hypertrophy in diabetes.

miR133a regulates cardiomyocyte hypertrophy in diabetes.

http://www.wikidata.org/entity/Q43219265

about

Epigenetic modifications and diabetic retinopathy The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives Human genetics of diabetic vascular complications Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes Diabetic cardiomyopathy: where we are and where we are going.H2S and homocysteine control a novel feedback regulation of cystathionine beta synthase and cystathionine gamma lyase in cardiomyocytes.MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes.Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.Gadd45α: a novel diabetes-associated gene potentially linking diabetic cardiomyopathy and baroreflex dysfunction.MicroRNA-301a mediated regulation of Kv4.2 in diabetes: identification of key modulators.MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy Diabetes complications: the microRNA perspective.MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damage A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes.MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy.miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes ASK1 modulates the expression of microRNA Let7A in microglia under high glucose in vitro condition.Induction of autophagy markers is associated with attenuation of miR-133a in diabetic heart failure patients undergoing mechanical unloading.MicroRNAs and diabetic complications Predictors and prevention of diabetic cardiomyopathy.Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases.Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects.MicroRNAs: potential mediators and biomarkers of diabetic complications.Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management.Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity.Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways Molecular mechanisms of diabetic cardiomyopathy.Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.MicroRNA regulation of autophagy in cardiovascular disease.Role of microRNAs in the pathogenesis of diabetic cardiomyopathy.Diabetic Cardiomyopathy: An Immunometabolic Perspective.Role of microRNAs in diabetes and its cardiovascular complications.Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

P2860

Q21284810-4DDC4FF3-8BCB-47AD-A021-3B93751CF961 Q26744743-F34B3B6A-EC79-4AD7-A39B-6366CFFA5670 Q26771750-E5F57A42-4677-4471-9334-ADB48101D895 Q27000709-49A457F3-9E85-4415-85C0-DF4F450B09F1 Q27002459-55C1D3FB-B039-4938-8B25-165BBB97EDCB Q28116103-FEF5000D-33CE-4527-BD12-73A6D290CA6B Q28293366-67AC10C6-A256-4CC8-B1C6-576A92522735 Q28392445-5FFA0099-7887-4B1A-88E2-5A5DB156AAE4 Q33671476-A382142C-3BFB-4862-A84C-BD7F3467FEF2 Q33690717-C156E87F-D4C9-4D84-8B8C-D3A64B709930 Q33808178-002603E1-2D54-4099-8390-3DC35B72F30B Q33829505-5E9602CC-E93F-4E22-8E32-5599BDBC42C8 Q34001116-96D9D778-08A3-4C6E-BD24-6AD218A03D6E Q34506855-3C76246B-40D5-461A-94B8-DDD9F345BA4F Q34662020-8CF41A6F-186B-473F-9205-976A6DB3D1CB Q34718910-AC12698F-2CBB-4DB0-9109-BE0A5C3B6CF3 Q35063237-DF785739-9C33-4281-B72F-4E550CE7C46F Q35063263-43B004F1-5EF0-49B2-9489-C1EE43F47A25 Q35070159-DD9E2977-FFFE-4783-9733-48DBDF8935E8 Q35129485-3492AA41-0D3A-481F-A7AB-4EBBAFCF4579 Q35167928-3DA6636D-5406-4189-B179-AC2B35F00577 Q35404898-1F7E972C-5EC6-4A2E-8692-DA5598E2319D Q35561647-8E32B7C4-9A66-47DF-92A6-D12D4F8E5660 Q35626060-9BC9A803-30F8-4A94-A86A-1718703C22D2 Q35682591-7BB17860-3AAB-42D7-9202-2C29DF7BCD76 Q36094855-EDA776F6-1A34-4DE1-9CC8-1C20C57E0817 Q36776922-FD5BF38A-C55E-4BA8-A65B-1FECE843ECDA Q36902427-15861A80-AC42-4AA3-B857-4C9F94F058C0 Q37056996-9DCE2F88-0B73-48D4-A0A5-D55306CF4824 Q37146727-B29B3C75-B99E-4B97-935E-47F9584399D4 Q37232675-185FC5D0-0011-4554-9671-7C2933C42001 Q37234922-B453FE4A-2C72-418B-9CAC-2898036651BB Q37586770-0A4D7214-712F-4546-A59F-630A0CEC0748 Q37672583-46C8745A-E058-4C8B-A869-3835B87B9F12 Q37685243-7A22EE13-3948-4AA8-A709-1449CD2EFCC1 Q37698507-DFBC08D9-538B-4FB9-B4B6-CDB58FFB151C Q37700697-F6E41D28-4B88-474F-B8F7-29E14B0BD0D8 Q37741735-9F1EF23D-5919-4C05-B37B-46863821F2BC Q37953896-851BB902-B963-4F31-8DE9-A9F2BB93F7CC Q38083574-2E59D21C-1ED0-4E1D-9A08-84E3D9247EE4

P2860

miR133a regulates cardiomyocyte hypertrophy in diabetes.

http://www.wikidata.org/entity/Q43219265

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

miR133a regulates cardiomyocyte hypertrophy in diabetes.

@en

miR133a regulates cardiomyocyte hypertrophy in diabetes.

@nl

type

label

miR133a regulates cardiomyocyte hypertrophy in diabetes.

@en

miR133a regulates cardiomyocyte hypertrophy in diabetes.

@nl

prefLabel

miR133a regulates cardiomyocyte hypertrophy in diabetes.

@en

miR133a regulates cardiomyocyte hypertrophy in diabetes.

@nl

P1433

Q43219265-2947DA43-57D2-40EA-AF43-E5F333A9D858

P1476

Q43219265-4B15BDA3-8DFE-4C18-8DBC-26B79A27998A

P2093

Q43219265-18DB19B2-1D1E-4819-B849-9A78F640F291

Q43219265-1CDD4320-4C55-4C24-921F-1095B2B357BB

Q43219265-7D22BE37-C581-40D2-8B45-B3B2E85BB443

Q43219265-984484A0-F69D-4460-87F5-DB33D98D7DC7

P304

Q43219265-C90D8EDA-CF98-4BD3-9E2A-391CD450297A

P31

Q43219265-9A3F0C44-3FE8-45B0-9E86-6FD001378EA9

P356

Q43219265-F98F66A9-E146-4035-83ED-48206D1C1146

P433

Q43219265-A4A4BEF5-7399-4E1A-B69A-17B12F679305

P478

Q43219265-9D320229-E69A-4C54-A44A-7CEE047B8A4E

P50

Q43219265-FCD59276-6E8B-4649-A294-EE8071B7130C

P577

Q43219265-5D26F11F-F3CF-4C90-8F45-5552DA8E91EB

P698

Q43219265-923158F1-CA18-4E5B-BB14-7E9C361E081B

P356

P1433

Diabetes - Metabolism: Research and Reviews

P1476

miR133a regulates cardiomyocyte hypertrophy in diabetes

@en

P2093

Biao Feng

http://www.w3.org/2001/XMLSchema#string

Biju George

http://www.w3.org/2001/XMLSchema#string

Qingping Feng

http://www.w3.org/2001/XMLSchema#string

Shali Chen

http://www.w3.org/2001/XMLSchema#string

P304

40-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DMRR.1054

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Subrata Chakrabarti

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20013939

http://www.w3.org/2001/XMLSchema#string